Non-melanoma skin cancer
暂无分享,去创建一个
[1] A. Brice,et al. PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study , 2006, British Journal of Cancer.
[2] O. Wisco,et al. Letter: Embryologic Fusion Planes A Plea for More Precise Analysis , 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[3] M. Kastan,et al. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Dummer,et al. Imiquimod in basal cell carcinoma: how does it work? , 2003, The British journal of dermatology.
[5] Michael Dean,et al. Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome , 1996, Cell.
[6] S. Dinehart,et al. Evaluation of the American Joint Committee on Cancer Staging System for Cutaneous Squamous Cell Carcinoma and Proposal of a New Staging System , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[7] S. Chimenti,et al. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers , 2007, The British journal of dermatology.
[8] T. Maurer,et al. Cutaneous malignancy and human immunodeficiency virus disease. , 2006, Journal of the American Academy of Dermatology.
[9] A. Gavin,et al. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services , 2007, The British journal of dermatology.
[10] C. Smith,et al. Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual. , 1996, Carcinogenesis.
[11] Henricus J C M Sterenborg,et al. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. , 2006, The Journal of investigative dermatology.
[12] K. Mckenna,et al. Guidelines for Topical Photodynamic Therapy: Update. On behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. , 2008 .
[13] L. Golitz,et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. , 2004, Journal of the American Academy of Dermatology.
[14] M. Veness. Time to rethink TNM staging in cutaneous SCC. , 2008, The Lancet. Oncology.
[15] R. Stern,et al. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. , 1998, Journal of the National Cancer Institute.
[16] R. Willemze,et al. Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin , 2005, The British journal of dermatology.
[17] S. Salasche,et al. Epidemiology of actinic keratoses and squamous cell carcinoma. , 2000, Journal of the American Academy of Dermatology.
[18] C. Garbe,et al. A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. , 2007, Journal of the American Academy of Dermatology.
[19] M. Karagas,et al. Allelic loss at Drosophila patched gene is highly prevalent in Basal and squamous cell carcinomas of the skin. , 2006, The Journal of investigative dermatology.
[20] K. Malinovszky,et al. Changing trends in non‐melanoma skin cancer in South Wales, 1988–98 , 2000, The British journal of dermatology.
[21] S. Campbell,et al. Clinical investigation of the novel iron‐chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma , 2008, The British journal of dermatology.
[22] J. Lear,et al. Basal cell carcinoma: from host response and polymorphic variants to tumour suppressor genes , 2005, Clinical and experimental dermatology.
[23] D. Jones,et al. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. , 1990, Journal of the American Academy of Dermatology.
[24] A. Grammatica,et al. Radiotherapy of recurrent basal and squamous cell skin carcinomas: a study of 249 re-treated carcinomas in 229 patients. , 2001, European journal of dermatology : EJD.
[25] P. Stewart,et al. Occupation and keratinocyte cancer risk: a population-based case–control study , 2007, Cancer Causes & Control.
[26] R N Hoover,et al. The emerging epidemic of melanoma and squamous cell skin cancer. , 1989, JAMA.
[27] M. Wolter,et al. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas , 2005, The British journal of dermatology.
[28] J. Shay,et al. The reactivation of telomerase activity in cancer progression. , 1996, Trends in genetics : TIG.
[29] B. Diffey,et al. Skin cancer incidence and the ageing population , 2005, The British journal of dermatology.
[30] M. Williams,et al. Dermatitis in treated maple syrup urine disease. , 1993, Journal of the American Academy of Dermatology.
[31] C. Otley. Non‐Hodgkin lymphoma and skin cancer: A dangerous combination , 2006, The Australasian journal of dermatology.
[32] R. Griffiths,et al. Do basal cell carcinomas recur after complete conventional surgical excision? , 2005, British journal of plastic surgery.
[33] S. Ibbotson,et al. The photocarcinogenic risk of narrowband UVB (TL‐01) phototherapy: early follow‐up data , 2005, The British journal of dermatology.
[34] P. Steijlen,et al. Fractionated 5‐aminolaevulinic acid–photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial , 2008, The British journal of dermatology.
[35] A. Dorevitch,et al. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes. , 1997, Archives of dermatology.
[36] A. Aupérin,et al. Evaluation of Cosmetic Results of a Randomized Trial Comparing Surgery and Radiotherapy in the Treatment of Basal Cell Carcinoma of the Face , 2000, Plastic and reconstructive surgery.
[37] C. Tabin,et al. Biochemical evidence that Patched is the Hedgehog receptor , 1996, Nature.
[38] D. Brash. Roles of the transcription factor p53 in keratinocyte carcinomas , 2006, The British journal of dermatology.
[39] K. Giercksky,et al. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. , 2001, The British journal of dermatology.
[40] R. Kelly,et al. Low density lipoprotein receptor and cation-independent mannose 6- phosphate receptor are transported from the cell surface to the Golgi apparatus at equal rates in PC12 cells , 1992, The Journal of cell biology.
[41] K. Cooper,et al. The health impact of solar radiation and prevention strategies: Report of the Environment Council, American Academy of Dermatology. , 1999, Journal of the American Academy of Dermatology.
[42] Rachel E Neale,et al. Basal cell carcinoma on the trunk is associated with excessive sun exposure. , 2007, Journal of the American Academy of Dermatology.
[43] M. Chren,et al. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. , 2007, The Journal of investigative dermatology.
[44] J. McGregor,et al. Human papillomavirus infection and non‐melanoma skin cancer in immunosuppressed and immunocompetent individuals , 2000, Journal of medical virology.
[45] A. Webster,et al. Interventions for preventing non-melanoma skin cancers in high-risk groups. , 2007, The Cochrane database of systematic reviews.
[46] Michele T. Cooper,et al. Photodynamic therapy for the treatment of basal cell carcinoma. , 1992, Archives of dermatology.
[47] A. Sedda,et al. Dermatological high‐dose‐rate brachytherapy for the treatment of basal and squamous cell carcinoma , 2008, Clinical and experimental dermatology.
[48] Y. Ho,et al. Telomerase activity of basal cell carcinoma in patients living in North Queensland, Australia. , 2007, Human pathology.
[49] N. Basset-Seguin,et al. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient. , 2002, The Journal of investigative dermatology.
[50] H. Ananthaswamy,et al. p53 and the pathogenesis of skin cancer. , 2007, Toxicology and applied pharmacology.
[51] Jian Liu,et al. Incidence of Nonmelanoma Skin Cancer in New Brunswick, Canada, 1992 to 2001 , 2007, Journal of cutaneous medicine and surgery.
[52] R. Kleinerman. Radiation-sensitive genetically susceptible pediatric sub-populations , 2009, Pediatric Radiology.
[53] X. Matías-Guiu,et al. Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up. , 2007, Archives of dermatology.
[54] P J Heenan,et al. A dose‐response curve for sun exposure and basal cell carcinoma , 1995, International journal of cancer.
[55] F. Vazquez-Lopez,et al. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation. , 2007, Journal of the American Academy of Dermatology.
[56] P. G. Lang,et al. Prognostic Factors for Metastasis in Squamous Cell Carcinoma of the Skin , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[57] R. Marks,et al. Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double‐blind, randomized, placebo‐controlled, parallel group, multicenter study , 2007, International journal of dermatology.
[58] S. Karrer,et al. Towards a more specific therapy: targeting nonmelanoma skin cancer cells , 2006, The British journal of dermatology.
[59] E. de Villiers,et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. , 1996, Journal of the National Cancer Institute.
[60] H. Comber,et al. A population‐based study of skin cancer incidence and prevalence in renal transplant recipients , 2006, The British journal of dermatology.
[61] C. Lawrence,et al. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. , 2003, The British journal of dermatology.
[62] D. Leffell,et al. Correlation of Embryonic Fusion Planes with the Anatomical Distribution of Basal Cell Carcinoma , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[63] H. Comber,et al. The role of immunosuppression in the pathogenesis of basal cell carcinoma , 2006, The British journal of dermatology.
[64] R. Glogau. The risk of progression to invasive disease. , 2000, Journal of the American Academy of Dermatology.
[65] H. Gollnick,et al. Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. , 2008, European journal of dermatology : EJD.
[66] N. Kiviat,et al. Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. , 2008, The Journal of investigative dermatology.
[67] Kari Stefansson,et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma , 2008, Nature Genetics.
[68] D. Roberts,et al. Variations in registration of skin cancer in the United Kingdom , 2004, Clinical and experimental dermatology.
[69] M. Veness. Defining patients with high‐risk cutaneous squamous cell carcinoma , 2006, The Australasian journal of dermatology.
[70] D. Brewster,et al. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992–2003 , 2007, The British journal of dermatology.
[71] G. Rennie,et al. MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA , 1988, The Lancet.
[72] B. Berne,et al. PUVA and cancer: a large-scale epidemiological study , 1991, The Lancet.
[73] M. Karagas,et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. , 2006, Journal of the National Cancer Institute.
[74] H. Williams,et al. Interventions for basal cell carcinoma of the skin. , 2007, The Cochrane database of systematic reviews.
[75] O. Chevallier-Lagente,et al. Ultraviolet responses of Gorlin syndrome primary skin cells , 2008, The British journal of dermatology.
[76] M. Turner,et al. Guidelines of care for cutaneous squamous cell carcinoma. Committee on Guidelines of Care. Task Force on Cutaneous Squamous Cell Carcinoma. , 1993, Journal of the American Academy of Dermatology.
[77] N. Demirkan,et al. Value of p53 protein in biological behavior of basal cell carcinoma and in normal epithelia adjacent to carcinomas , 2010, Pathology & Oncology Research.
[78] R. Stern,et al. Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study. , 2007, The Journal of investigative dermatology.
[79] Graham G Giles,et al. Non‐melanoma skin cancer in Australia: the 2002 national survey and trends since 1985 , 2006, The Medical journal of Australia.
[80] J. Zitelli,et al. Surgical margins for basal cell carcinoma. , 1987, Archives of dermatology.
[81] H. Soyer,et al. Keratoacanthoma: A Clinically Distinct Variant of Well Differentiated Squamous Cell Carcinoma , 1998, Advances in anatomic pathology.
[82] J. Lear,et al. Systemic photodynamic therapy with Photofrin for naevoid basal cell carcinoma syndrome-A pilot study. , 2005, Photodiagnosis and photodynamic therapy.
[83] C. Morton,et al. Guidelines for topical photodynamic therapy: update , 2008, The British journal of dermatology.
[84] P. Boffetta,et al. Tobacco smoking, snuff dipping and the risk of cutaneous squamous cell carcinoma: a nationwide cohort study in Sweden , 2005, British Journal of Cancer.
[85] Igal Leibovitch,et al. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. , 2005, Journal of the American Academy of Dermatology.
[86] S. Allinson,et al. Cellular and sub-cellular responses to UVA in relation to carcinogenesis , 2009, International journal of radiation biology.
[87] A. Sarasin,et al. Differential behaviors toward ultraviolet A and B radiation of fibroblasts and keratinocytes from normal and DNA-repair-deficient patients. , 1999, Cancer research.
[88] D. Eedy,et al. Guidelines for management of Bowen's disease: 2006 update , 2007, The British journal of dermatology.
[89] R. Strange,et al. Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy , 2000, The British journal of dermatology.
[90] A. Aupérin,et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. , 1997, British Journal of Cancer.
[91] D. Ratner,et al. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? , 2007, Cancer.
[92] R. Carroll,et al. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. , 1989, The Journal of dermatologic surgery and oncology.
[93] L. Naldi,et al. The epidemiology of skin cancer , 2002, The British journal of dermatology.
[94] V. Gebski,et al. Surgery and Adjuvant Radiotherapy in Patients with Cutaneous Head and Neck Squamous Cell Carcinoma Metastatic to Lymph Nodes: Combined Treatment Should be Considered Best Practice , 2005, The Laryngoscope.
[95] Rik Roelandts,et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. , 2008, European journal of dermatology : EJD.
[96] G. Kricorian,et al. 5% 5‐Fluorouracil Cream for the Treatment of Small Superficial Basal Cell Carcinoma: Efficacy, Tolerability, Cosmetic Outcome, and Patient Satisfaction , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[97] D. English,et al. Does intermittent sun exposure cause basal cell carcinoma? a case‐control study in Western Australia , 1995, International journal of cancer.
[98] M. Karagas,et al. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group. , 2000, Archives of dermatology.
[99] T. Lotti,et al. Vascular based non conventional dye laser treatment for basal cell carcinoma , 2008, Dermatologic therapy.
[100] J. Hercogová,et al. Superpulsed CO2 Laser Treatment of Basal Cell Carcinoma With Intraoperatory Histopathologic and Cytologic Examination , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[101] A. Katalinic,et al. Epidemiology of cutaneous melanoma and non‐melanoma skin cancer in Schleswig‐Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer) , 2003, The British journal of dermatology.
[102] T. M. Rünger. How different wavelengths of the ultraviolet spectrum contribute to skin carcinogenesis: the role of cellular damage responses. , 2007, The Journal of investigative dermatology.
[103] V. L. Hall,et al. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. , 1986, Clinical radiology.
[104] G. Murphy,et al. Update on the pathogenesis of post‐transplant skin cancer in renal transplant recipients , 2007, The British journal of dermatology.
[105] Andrew G Smith,et al. Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype. , 2001, Pharmacogenetics.
[106] R. Stern,et al. Incidence of skin cancer in 5356 patients following organ transplantation , 2000, The British journal of dermatology.
[107] C. Dirksen,et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. , 2008, The Lancet. Oncology.
[108] R. Westendorp,et al. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. , 1998, The Journal of investigative dermatology.
[109] J. Huber,et al. Topical Imiquimod Treatment for Nodular Basal Cell Carcinomas: An Open‐Label Series , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[110] R. Westendorp,et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. , 2001, American journal of human genetics.
[111] M. Feltkamp,et al. Beta-papillomavirus infection and skin cancer. , 2008, The Journal of investigative dermatology.
[112] D. Gawkrodger,et al. Occupational skin cancers. , 2004, Occupational medicine.
[113] H. Mukhtar. Skin Cancer: Mechanisms and Human Relevance , 1994 .
[114] M. Landthaler,et al. Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors. , 1995, Archives of dermatology.
[115] Menno A de Rie,et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. , 2007, Archives of dermatology.
[116] A. Oseroff,et al. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. , 2003, Molecular immunology.
[117] C. A. Thissen,et al. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. , 2006, Journal of drugs in dermatology : JDD.
[118] R. Dawber,et al. Cryosurgery in the Treatment of Basal Cell Carcinoma: Assessment of One and Two Freeze‐Thaw Cycle Schedules , 1996, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[119] Rippey. Why classify basal cell carcinomas? , 1998, Histopathology.
[120] M. Veness,et al. The important role of radiotherapy in patients with non‐melanoma skin cancer and other cutaneous entities , 2008, Journal of medical imaging and radiation oncology.
[121] M A A Neil,et al. Fluorescence lifetime imaging distinguishes basal cell carcinoma from surrounding uninvolved skin , 2008, The British journal of dermatology.
[122] F. Reymann. Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study. , 1979, Dermatologica.
[123] W. Sterry. Guidelines: the management of basal cell carcinoma. , 2006, European journal of dermatology : EJD.
[124] Chin Y Liu. Fluorouracil for Allergic Reactions to Capecitabine , 2002, The Annals of pharmacotherapy.
[125] S. Stringer,et al. Skin cancer of the head and neck with clinical perineural invasion. , 2000, International journal of radiation oncology, biology, physics.
[126] G. Fontanini,et al. Evaluation of telomerase in non-melanoma skin cancer. , 2003, International journal of molecular medicine.
[127] T. Humphreys,et al. Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ with a high-energy pulsed carbon dioxide laser. , 1998, Archives of dermatology.
[128] Telfer Nr,et al. Guidelines for the management of basal cell carcinoma. British Association of Dermatologists. , 1999 .
[129] Gail M. Williams,et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial , 1999, The Lancet.
[130] J. Lear,et al. Cutaneous basal cell carcinomas , 2001, Cancer.
[131] I. Ruczinski,et al. Nonmelanoma skin cancer and risk for subsequent malignancy. , 2008, Journal of the National Cancer Institute.
[132] J. Shapiro,et al. Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles. , 2008, The Journal of investigative dermatology.
[133] R. Carroll,et al. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. , 1989, The Journal of dermatologic surgery and oncology.
[134] P. Walker,et al. Surgical treatment of basal cell carcinomas using standard postoperative histological assessment , 2006, The Australasian journal of dermatology.
[135] R. Goldwyn,et al. Long‐Term Results of Irradiation for Basal Cell Carcinoma of the Skin of the Nose , 1994, Plastic and reconstructive surgery.
[136] Bruce K. Armstrong,et al. Sunlight and cancer , 1997, Cancer Causes & Control.
[137] R. Carroll,et al. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. , 1992, Journal of the American Academy of Dermatology.
[138] M. Thissen,et al. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. , 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[139] A. Bradley,et al. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC , 1995, Nature.
[140] B. Schönfisch,et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. , 2008, The Lancet. Oncology.
[141] S. Rosso,et al. The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. , 1996, British Journal of Cancer.
[142] M. Weinstock,et al. Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy. , 1995, Archives of dermatology.
[143] H. Kerl,et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification , 2007, The British journal of dermatology.
[144] M. Ulrich,et al. Noninvasive diagnostic tools for nonmelanoma skin cancer , 2007, The British journal of dermatology.
[145] Daniel J. Gould,et al. Treatment of basal cell carcinoma by dermatologists in the United Kingdom , 1995, British Journal of Dermatology.
[146] S. Tucker,et al. Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy. , 2006, Journal of the American Academy of Dermatology.
[147] C. Morton,et al. Guidelines for the management of basal cell carcinoma , 2008, The British journal of dermatology.